文献速递细菌感染、耐药与抗菌药物医院感染防控

验证VIRSTA与PREDICT评分确定金黄色葡萄球菌菌血症患者超声心动图优先级的价值

Validation of VIRSTA and Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT) Scores to Determine the Priority of Echocardiography in Patients With Staphylococcus aureus Bacteremia.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究在哥伦比亚两家高复杂度医院纳入2012至2018年住院的金黄色葡萄球菌菌血症患者922例,评估VIRSTA与PREDICT评分预测感染性心内膜炎的性能。结果显示VIRSTA阴性者IE频率仅0.44%,敏感性96.7%、阴性预测值99.5%;PREDICT第5天阴性者IE频率4.8%,敏感性51.6%、阴性预测值95.1%。VIRSTA阴性可考虑省略筛查超声,PREDICT阴性则不安全。

要点

  • VIRSTA阴性患者IE频率0.44%,阴性预测值99.5%,可考虑省略筛查超声。
  • PREDICT第5天阴性患者IE频率4.8%,阴性预测值95.1%,不能安全省略超声。
  • VIRSTA的AUC为0.86,优于PREDICT的0.64。

核心结论

  • VIRSTA阴性患者因IE频率低,筛查超声心动图可能不必要。
  • PREDICT阴性患者尽管IE频率低,省略超声心动图并不安全。

研究设计与样本

  • 哥伦比亚麦德林两家高复杂度医院的住院SAB患者队列,2012至2018年。
  • 最终分析纳入922例患者,其中62例(6.7%)诊断为IE。
  • IE诊断基于修改版Duke标准,从临床记录计算VIRSTA与PREDICT评分并评估操作性能。

主要发现

  • VIRSTA阴性患者IE频率为0.44%(2/454)。
  • PREDICT第5天阴性患者IE频率为4.8%(30/622)。
  • VIRSTA敏感性96.7%、阴性预测值99.5%;PREDICT第5天敏感性51.6%、阴性预测值95.1%。
  • VIRSTA的AUC为0.86,PREDICT的AUC为0.64。

关键数值与推荐

  • VIRSTA阴性:IE频率0.44%(2/454),敏感性96.7%,阴性预测值99.5%,AUC 0.86。
  • PREDICT第5天阴性:IE频率4.8%(30/622),敏感性51.6%,阴性预测值95.1%,AUC 0.64。

临床怎么用

  • 对SAB患者可计算VIRSTA评分,阴性者考虑省略筛查超声心动图。
  • PREDICT第5天阴性者不应据此省略超声心动图。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infective endocarditis (IE) secondary to Staphylococcus aureus bacteremia (SAB) has high morbidity and mortality. The systematic use of echocardiography in SAB is controversial. We aimed to validate VIRSTA and Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT) scores for predicting the risk of IE in Colombian patients with SAB and, consequently, to determine the need for echocardiography. METHODS: Cohort of patients hospitalized with SAB in 2 high complexity institutions in Medellin, Colombia, between 2012 and 2018. The diagnosis of IE was established based on the modified Duke criteria. The VIRSTA and PREDICT scores were calculated from the clinical records, and their operational performance was calculated. RESULTS: The final analysis included 922 patients, 62 (6.7%) of whom were diagnosed with IE. The frequency of IE in patients with a negative VIRSTA scale was 0.44% (2/454). The frequency of IE in patients with a negative PREDICT scale on day 5 was 4.8% (30/622). The sensitivity and negative predictive value (NPV) of the VIRSTA scale was 96.7% and 99.5%, respectively. For the PREDICT scale on day 5, the sensitivity and NPV were 51.6% and 95.1%, respectively. The discrimination, given by the area under the receiver operating characteristic curve, was 0.86 for VIRSTA and 0.64 for PREDICT. CONCLUSIONS: In patients with negative VIRSTA, screening echocardiography may be unnecessary because of the low frequency of IE. In PREDICT-negative patients, despite the low frequency of IE, it is not safe to omit echocardiography.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Peinado-Acevedo JS, Hurtado-Guerra JJ, Hincapié C, et al. Validation of VIRSTA and Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT) Scores to Determine the Priority of Echocardiography in Patients With Staphylococcus aureus Bacteremia. Clin Infect Dis. 2021. PMID: 34492692. doi:10.1093/cid/ciaa1844

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。